After treatment for multiple myeloma, Bryon Daily pays it forward to other African Americans, who are at higher risk for this cancer.

Ivosidenib (Tibsovo) plus chemotherapy may soon be an option for those with leukemia that has an IDH1 mutation.

Age, sex and decade of diagnoses influenced long-term survival of adolescent and young adult leukemia survivors.

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.

Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia.

Minimal residual disease status may not be as strong a predictor of relapse in Latino children.

CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.

A new clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia. Here’s how to get more info.

Removing naive T cells before a stem cell transplant in certain cancer patients may prevent chronic graft-versus-host disease.

Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements.